| #390 |
Haiyan Liu |
Smithkline Beecham Limited |
1 |
| #390 |
James C. Hershey |
Merck |
1 |
| #390 |
Shane W. Obrien |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Kurt A. Bolz, III |
Dow Global Technologies |
1 |
| #390 |
Jason Anthony Rossi |
Glaxo Group Limited |
1 |
| #390 |
Lihua(lily) Zhang |
Glaxo Group Limited |
1 |
| #390 |
Sangeeta Raje |
Solvay Pharmaceuticals, B.V. |
1 |
| #390 |
Jeremy Wang |
— |
1 |
| #390 |
Maciej M. Markiewski |
University of Pennsylvania |
1 |
| #390 |
Kurt R. Auger |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #390 |
Sarper Toker |
Asana Biosciences |
1 |
| #390 |
Mark L. Ticktin |
Eresearchtechnology |
1 |
| #390 |
Dan Davenport |
Globus Medical |
1 |
| #390 |
Sapna Yadavilli |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Heather L. Jackson |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Niranjan YANAMANDRA |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Paul M. Bojczuk |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Sabyasachi Bhattacharya |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Mark L. Belangee |
Numerex |
1 |
| #390 |
Shared Kumar Verma |
Glaxosmithkline |
1 |
| #390 |
Girish Chawla |
Oracle |
1 |
| #390 |
Rachel Apfelbaum |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #390 |
Dave Fuhrmeister |
Pfizer |
1 |
| #390 |
Jean-Luc Tran |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Jingsong YANG |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Rosaleen Patricia Morris-Oskanian |
Air Products And Chemicals |
1 |
| #390 |
Rosaleen Oskanian |
Draegerwerk Ag & Co. Kgaa |
1 |
| #390 |
Matthew ELIZARDO |
University Of Delaware |
1 |
| #390 |
Ryan Charlton |
Lehigh University |
1 |
| #390 |
Erica A. Frankel |
Dow Global Technologies |
1 |
| #390 |
Jason Burgese |
— |
1 |
| #390 |
Walt Singleton |
Siemens Medical Solutions Usa |
1 |
| #390 |
Vargheese M. Chennathukuzhi |
Pfizer |
1 |
| #390 |
Meghan Koback |
Dow Global Technologies |
1 |
| #390 |
Yanli Gong |
Rohm And Haas |
1 |
| #390 |
Phillip A. Billiard |
The Boeing |
1 |
| #390 |
Todd Behrens |
Unknown |
1 |
| #390 |
Derek Behrens |
Unknown |
1 |
| #390 |
Courtney Behrens |
Unknown |
1 |
| #390 |
Mul Cheung |
Glaxosmithkline |
1 |
| #390 |
Ping-Chiao Tsai |
23Andme |
1 |
| #390 |
Sigfried B. Christensen, IV |
Glaxosmithkline |
1 |
| #390 |
Qiming Chen |
Immunogen |
1 |
| #390 |
Venkat Dandibhotla |
Siemens Medical Solutions Usa |
1 |
| #390 |
Yujie LIU |
23Andme |
1 |
| #390 |
Mary Beth Dorr |
Merck |
1 |
| #390 |
Shugui Chen |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Eric Burkholder |
Johnson Matthey Public Limited |
1 |
| #390 |
Alezander I. Kuklin |
Transgenomic |
1 |
| #390 |
Walter S. Lewandowski |
Sperry |
1 |